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hate. ArAbstract A novel vanadium dodecylamino phosphate was synthesized by mixing phosphoric acid
and vanadyl acetylacetonate with dodecylamine at ambient temperature. The material was charac-
terized by various spectroscopic and analytical techniques to know its morphological and structural
characteristics. The biological activity of the material toward antimicrobial, nematicidal, DNA
cleavage and cytotoxicity has been screened. The material exhibits moderate to good antimicrobial
activity against Gram-positive bacteria. The percentage mortality on Meloidogyne incognita nema-
tode was found to increase with increase in concentration of VDDAP at 48 h. Further, the material
was investigated for cytotoxicity on human cancer cell lines such as cervix (HeLa), leukemia (HL60)
and breast (MCF7). The cells were dosed with varying concentrations of the VDDAP and cell via-
bility was measured by sulforhodamine B (SRB) assay to determine their GI50 values. Interestingly,
the compound shows GI50 values of 25.4 lg mL1 (HeLa), 29.1 lg mL1 (MCF7) and a superior
value of 11.6 lg mL1 (HL60) respectively. The DNA cleavage activity of the material was inves-
tigated using agarose gel electrophoresis.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The ﬁght against cancer is the primary target concerning medic-
inal chemistry. Cis-platin and carboplatin are some of the
widely used chemotherapeutic drugs. However these drugs9491319976.
om (N. Venkatathri).
Saud University.
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in medicine. Recently, non platinum group metals are found
to exhibit pronounced in vivo and in vitro activities against var-
ious tumor cell lines. As platinum group metals are costly and
difﬁcult to procure at low costs, researchers look forward to the
application of non platinum group metals toward anticancer
studies and focused in applying various transition metals in bio-
logical applications. The metal based compounds such as vana-
dium, titanium, copper, ruthenium, tin and rhodium have been
reported with promising chemotherapeutic potentials (Ott and
Gust, 2007). Among the metal based compounds, vanadium
compounds have been implicated in many biological processes
like cell growth and known to possess therapeutic applicationsing Saud University.
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2 A. Rajini et al.such as anticancer (Shahzadi et al., 2010), anti-diabetic
(Thompson et al., 1999) and anti-HIV properties.
Vanadium is an essential element for various biological
functions and used in biochemistry and cell biology (Chasteen
et al., 1983) as a tool to characterize various molecular pro-
cesses. Vanadium ions can play a major role in biology as
counter ions for protein, DNA, RNA and in various biological
organelles. Some compounds of vanadium induce apoptosis in
human leukemia, multiple myeloma and suppress the growth
of existing tumors by limiting the invasion and metastatic po-
tential of neoplastic cells (Benı´tez et al., 2011; Maia et al.,
2009). The compounds of vanadium are capable of regulating
signal transduction pathways, promote cell transformations,
enzyme activities, cell-to-cell communications and adhesions
(Morinville et al., 1998). Successful studies over the past few
decades have advanced the use of vanadium compounds as
anticancer agents in the preclinical stage for cancers of breast,
colon, liver and leukemia. (Bishayee et al., 2010).
The nuclease activity of vanadium compounds was ﬁrst re-
ported in Shi et al. (1996) for VOSO4 in the presence of Hydro-
gen peroxide. Several cationic V3+ dimeric complexes with
1,10-phenanthroline were shown to have nuclease activity
(Heater et al., 2000). Verquin et al. (2004) synthesized V4+com-
plexes with hydroxysalen ligands which shows nuclease activity
in the presence of an activating agent, either a reducing mercap-
topropionic acid (MPA) or an oxidizing oxone (KHSO5). In the
present study, we report a novel vanadium dodecylamino phos-
phate prepared instantly by simple mixing of its precursors at
ambient temperature. The material was characterized by vari-
ous physicochemical techniques such as powder XRD, SEM-
EDAX, FT-IR, Raman spectroscopy, UV–Vis DRS, 31P and
13CMAS NMR. As part of our study we have investigated bio-
logical activity such as antimicrobial, DNA cleavage and cyto-
toxicity of vanadium dodecylamino phosphate.
2. Experimental
2.1. Materials
Vanadyl acetylacetonoate (Sigma–Aldrich, India 98%), dode-
cylamine (Sigma–Aldrich, India 98%) and orthophosphoric
acid (Merck, India 85%) were obtained. All chemicals were
of analytical reagent grade and used as received without any
further puriﬁcation.
2.2. Synthesis of vanadium dodecylamino phosphate (VDDAP)
The synthesis of vanadium dodecylamino phosphate (VDDAP)
was carried out at ambient temperature as reported elsewhere
(Rajini et al., 2013). In a typical synthesis, a pre-determined
quantity of orthophosphoric acid (1 M) was added to vanadyl
acetylacetonoate (0.01 M) and stirred until the vanadyl acety-
lacetonoate was dissolved. Dodecylamine (4 M) was added to
this mixture and stirred well to obtain a solid product. The
product thus obtained was thoroughly washed with ether, dried
at 50 C for about 1 h and grounded to obtain VDDAP.
2.3. Characterization techniques
Qualitative phase analysis of VDDAP was performed using
a Bruker AXS D8 Advance diffractometer at ambientPlease cite this article in press as: Rajini, A. et al., Synthesis, charac
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1.5406 A˚ using a Si(Li) PSD detector. The morphology of
the synthesized material was investigated using a JEOL Model
JSM6390LV of scanning electron microscope (SEM) and the
surface elemental composition (EDAX) was examined using
a JEOL Model JED-2300. Fourier transform infrared (FT-
IR) spectra were recorded on a Thermo Nicolet Avatar 370
spectrophotometer equipped with a pyroelectric detector
(DTGS type) a resolution of 4 cm1 was adopted, provided
with a KBr beam splitter. Dispersive Raman spectroscopy
was performed on a Bruker Senterra at a wavelength of
532 nm using laser radiation as the source. The coordination
and the oxidation state of vanadium in VDDAP were exam-
ined by diffuse reﬂectance UV–Vis spectrophotometry (UV–
Vis DRS) on a Varian Cary 5000 in the range of 175–
800 nm. Solid state 31P magic angle spinning (MAS) nuclear
magnetic resonance (NMR) spectra were recorded on a Bruker
DRX-500 AV-III 500(S) spectrometer. The 31P MAS NMR
spectrum was recorded at 121.49 MHz in the frequency range
of 10–12 kHz using a 5 mm dual probe head of pulse duration
of 5 ls. The chemical shift was measured with regard to 85%
H3PO4 as the external reference. The solid state
13C magic an-
gle spinning (MAS) nuclear magnetic resonance (NMR) spec-
tra was recorded on a DSX-300 Avance-III 400(L) NMR
spectrometer. The 13C MAS NMR spectrum was recorded at
75.47 MHz in the frequency range of 10–12 kHz equipped with
using a 5 mm dual probe head of pulse duration 4.25 ls.
2.4. In vitro antimicrobial studies
The in vitro anti-bacterial and anti-fungal activities of the
VDDAP were tested against Gram-positive (Staphylococcus
aureus, Bacillus subtilis), Gram-negative bacteria (Pseudomo-
nas ﬂuorescens, Escherichia coli, and Proteus vulgaris) and fun-
gal species (Candida albicans) by the disc diffusion method.
The antibiotics ampicillin and clotrimazole are the standards
for anti-bacterial and anti-fungal activity studies. Nutrient
agar plate was evenly spread by using a sterile glass spreader.
Sterile antibiotic discs (Whatman No. 1 paper having the
diameter 6 mm) were placed over the medium. To determine
the antimicrobial activity, 100 lg mL1 of VDDAP initially
dissolved in dimethyl sulphoxide (DMSO) was transferred to
each disc with the help of a micropipette, simultaneously main-
taining standard ampicillin (30 lg/disc) against bacteria and
clotrimazole (10 lg/disc) for fungi. After overnight incubation
at 37 C for bacteria and 25 C for fungi, the zone of inhibition
was measured in ‘mm’ and compared with standard antibiot-
ics. Control measurements were carried out with DMSO. All
the experiments were performed in triplicate and the average
zone of inhibition was calculated. Minimum inhibitory concen-
tration (MIC) value of VDDAP was determined by using the
serial dilution method.
2.5. Nematicidal activity
Nematicidal activity was carried out onMeloidogyne incognita.
Nematode M. incognita is known to attack more than 3000
host plants (Reddy and Khan, 1991). The yields of okra, toma-
to and brinjal typically suffer 90.9%, 46.2% and 2.3% losses,
respectively due to M. incognita. M. incognita produces galls
on the roots of many host plants and is responsible for aterization, antimicrobial and cytotoxic studies of a novel vana-
13), http://dx.doi.org/10.1016/j.arabjc.2013.07.038
Figure 1 Powder X-ray diffraction pattern of VDDAP.
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galls on the roots of many vegetables, pulses, some fruit crops,
tobacco and ornamental crops and causes severe losses (Ka-
poor et al., 2012).
2.5.1. Culture preparation
Fresh egg masses of M. incognita were collected from stock
culture and maintained on tomato (Lycopersicum esculentum)
root tissues and kept in water for egg hatching. The eggs sus-
pension was poured on a cotton wool ﬁlter paper and incu-
bated at 28 ± 2 C to obtain freshly hatched juveniles.
Juveniles collected within 48 h were used for screening the
nematicidal activity of VDDAP.
2.5.2. Mortality test
VDDAP was initially dissolved in DMSO and then in distilled
water to make dilutions of 250, 150 and 50 lg mL1. Experi-
ments were performed under laboratory conditions at
28 ± 2 C. About 100 freshly hatched second stage juveniles
were suspended in 5 mL of each diluted compound and incu-
bated. Distilled water with nematode larvae has been em-
ployed as the control. The dead nematodes were observed
under an inverted binocular microscope. After an incubation
of 24 and 48 h, percentage mortality was calculated. Nema-
todes were considered dead, if they do not move when probed
with a ﬁne needle (Cayrol et al., 1989).
2.6. Agarose gel electrophoresis
5 lL of kDNA was added to 2 lL of each sample (for ve con-
trol no sample is added, for +ve control 2 lL FeSO4 and
VDDAP) seperately in eppendorf tubes. The contents were
incubated at 37 C for 1 h and then 10 lL of enzyme buffer,
1 lL of Hind III enzyme and 13 lL of deionized water were
added, incubated at 37 C for 3 h. The contents of the wells
were mixed with bromophenol dye and separated through elec-
trophoresis. Gel electrophoresis was performed at constant
voltage (70 V). Bands were visualized by viewing the gel under
UV light and photographed.
2.7. Anticancer activity
The cell lines were cultured in RPMI 1640 medium, supple-
mented with 10% fetal bovine serum (FBS) and 2 mM L-gluta-
mine at 37 C in a humidiﬁed atmosphere containing 5% CO2.
About 5 · 103 cells/well was seeded in 96-well micro titer plate
using a culture medium. After 24 h, the new medium with
VDDAP in the concentration of 10, 20, 40 and 80 lg mL1
was added to respective wells and incubated for 48 h. After
incubation the sulforhodamine B assay was performed.
2.7.1. Sulforhodamine B (SRB) assay
The cytotoxicity of VDDAP was assessed using a cell death as-
say based on detection of cells by sulforhodamine B (SRB), a
stain speciﬁc for proteins. The cells were inoculated into 96-
well micro titer plates in 90 lL at plating densities at a density
of 5 · 103 cells per well depending on the doubling time of indi-
vidual cell lines. After cell inoculation, the micro titer plates
were incubated for 24 h prior to the addition of standard.
After 24 h, one plate of each cell line was ﬁxed in situ with tri-
chloroaceticacid (TCA) to represent a measurement of the cellPlease cite this article in press as: Rajini, A. et al., Synthesis, charac
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Experimental drugs were solubilized in appropriate solvent
by 400-fold in the desired ﬁnal maximum test concentration
and stored frozen prior to use. At the time of drug addition,
an aliquot of frozen concentrate was thawed and diluted to
10 times the desired ﬁnal maximum test concentration with
complete medium containing test article at a concentration
of 103. Additionally three, 10-fold serial dilutions were made
to provide a total of four drug concentrations plus control.
Aliquots of 10 lL of these different drug dilutions were added
to the appropriate micro titer wells already containing 90 lL of
medium, resulting in the required ﬁnal drug concentration.
After the addition of compounds, plates were incubated for
48 h and the assay was terminated by the addition of cold
TCA. Cells were ﬁxed in situ by the gentle addition of 50 lL
of cold 30% (w/v) TCA (ﬁnal concentration, 10% TCA) and
incubated for 60 min at 4 C. Sulforhodamine B (SRB) solu-
tion (50 lL) at 0.4% (w/v) in 1% acetic acid has been added
to each well and the plates were incubated for 20 min at room
temperature. Bound stain was subsequently eluted with 10 mM
trizma base and the absorbance was read on an Elisa plate
reader at a wavelength of 540 nm with 690 nm reference wave-
length. Percentage growth was calculated on a plate by plate
basis for test wells relative to control wells. All experiments
were repeated for a minimum of three times with each experi-
ment done in four replicates. Adriamycin was served as the po-
sitive control compound in the cytotoxic assay.
3. Results and discussion
3.1. Powder XRD
The powder X-ray diffraction pattern (Fig. 1) of VDDAP
shows peaks at 2h of 5.5, 8.1,10.8, 13.5, 21.2, 22.2 and
the corresponding d-spacing’s are 15.9, 10.8, 8.1, 6.5, 4.1,
3.9 . The peaks at 2h of 21.2, 13.5, 22.2 indicate the presence
of vanadium ions (Xue et al., 2010) of VOPO4 phases (Pillai
and Sahle-Demessie, 2004; Rownaghi et al., 2009) and hy-
drated VOPO4 phases (VOHPO4.H2O) predominantly in the
V4+ state with a small amount of V5+ species in VDDAP
(Guan et al., 2008). Peak at 13.5 corresponds to the presenceterization, antimicrobial and cytotoxic studies of a novel vana-
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Figure 3 Energy dispersive X-ray analysis of VDDAP.
Figure 4 Fourier transform infrared spectrum of VDDAP.
4 A. Rajini et al.of hydrated VOPO4 phases (VOHPO4.H2O). The crystallite
size of the VDDAP was calculated by employing the Scherer’s
equation.
D ¼ 0:9k
b cos h
ð1Þ
where D represents the mean grain size, k is the wavelength
of X-ray radiation, b is the full width at half the maximum
height of the peak and h represents the diffraction angle. The
average crystallite size of VDDAP was found to be 2.09 nm.
3.2. SEM-EDAX
The scanning electron micrograph (Fig. 2) of VDDAP synthe-
sized using dodecylamine and vanadyl acetylacetonoate shows
that the particles have a ﬁbrous morphology with homogenous
phase. The energy dispersive X-ray analysis (Fig. 3) shows the
distribution of the constituent elements O, P, N and V in the
synthesized material.
3.3. FT-IR spectra
Fourier transform infrared spectrum (Fig. 4) of VDDAP shows
a peak at 540 cm1 associated with the V–O–V rotational vibra-
tions. The small edge at 2920 cm1 and the peak at 1475 cm1
correspond to the asymmetric stretching and bending vibrations
of methylene groups (–CH2) of the alkyl group. The peak at
approximately 1220–1080 cm1 corresponds to the C–N
stretching vibration. The peaks at 1085 cm1 and 1171 cm1
are due to the asymmetric stretching and anti-symmetric
stretching of the P–O bond, respectively (Borah and Datta,
2010). The band at 1240 cm1 can be ascribed to the asymmetric
stretching vibration mode of the P–O bond (Nagaraju et al.,
2008). The peaks in the range of 850–980 cm1 are attributed
to the stretching frequency of the –V‚O bond in VDDAP
(Nguyen-Phan et al., 2011). The peak at 889 cm1 corresponds
to the presence of condensed P–N units in VDDAP. The ab-
sence of bands at 1580 cm1 and 1540 cm1, which are charac-
teristic of the N-H bending vibrations of the NHþ3 group,
indicates that no protonation of amine has taken place (Datta
et al., 2005). The structure of VDDAP was found to possess
vanadium phosphate layers in which the amine molecules inter-
act with the vanadium and phosphate to form an open-frame-
work sandwiched polymeric material (Fig. 5).Figure 2 Scanning electron micrograph of VDDAP.
Please cite this article in press as: Rajini, A. et al., Synthesis, charac
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The dispersive Raman spectrum (Fig. 6) of VDDAP shows a
small peak at 880 cm1 corresponding to the presence of VOH-
PO4.H2O (Guliants et al., 1996) while the band at 1050 cm
1 is
assigned to the strong V–O–P band of the VOPO4 phase in
VDDAP (Went et al., 1990; Wu et al., 2010). The band near
to 945 cm1 corresponds to the symmetric stretching vibration
of the phosphate tetrahedron of the VOPO4 phase in VDDAP
(Benesˇ et al., 2006).
3.5. UV–Vis DRS spectra
The UV–Vis diffused reﬂectance spectra (Fig. 7) of VDDAP
shows a band at 250 nm due to the VO2+ species present in
the tetrahedral coordination. The band at 300–320 nm favors
high dispersion of V5+ ions in the tetrahedral environment
(Murgia et al., 2006; Wang et al., 2011). The UV–Vis diffuse
reﬂectance spectrum indicates that V4+ and V5+ ions are coex-
istent in VDDAP. The presence of a broad peak at 410–
460 nm is due to the charge transfer transitions of the V5+ spe-
cies (V‚O) in square pyramidal geometry.terization, antimicrobial and cytotoxic studies of a novel vana-
13), http://dx.doi.org/10.1016/j.arabjc.2013.07.038
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Figure 5 Mechanism proposed for the formation of VDDAP.
Figure 6 Dispersive Raman spectrum of VDDAP.
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Figure 7 UltraViolet–Visible diffuse reﬂectance spectrum of
VDDAP.
Figure 8 31P MAS NMR spectrum of VDDAP.
Synthesis, characterization, antimicrobial and cytotoxic studies of a novel vanadium dodecylamino phosphate 53.6. 31P MAS NMR
The solid state 31P MAS NMR spectrum (Fig. 8) of VDDAP
shows a sharp signal centered at d= 2.034 ppm. The signal
corresponds to the phosphorous atoms of the phosphate link-
age. The 31P MAS NMR signals in the d range from –22 to
4 ppm correspond to the phosphorous atoms of the VOPO4
phases. Only one resonance peak in the framework is a clear
indicator that all the phosphorous atoms are equivalent in
VDDAP (Bartley et al., 2001).Please cite this article in press as: Rajini, A. et al., Synthesis, charac
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The 13C MAS NMR spectrum (Fig. 9) of VDDAP shows that
the 13C chemical shift in the d range of 32–34 ppm due to the
alkyl chains of interior methylene carbons in trans conforma-
tion (Dasgupta et al., 2002). The peak at d= 14 ppm is due to
the interaction of the terminal methyl group of dodecylamine
with the VPO matrix. The peaks at d= 42.8 and
d= 39.4 ppm corresponds to the carbon (C1) adjacent to the
amine head group and the carbon (C2) next to it respectively,
indicating the strong interaction of the amine head group with
the vanadium phosphate matrix (Dasgupta et al., 2004).
3.8. Antimicrobial activity
The antimicrobial activity of VDDAP was evaluated against
bacterial species S. aureus, B. subtilis, P. ﬂuorescens, E. coli,terization, antimicrobial and cytotoxic studies of a novel vana-
13), http://dx.doi.org/10.1016/j.arabjc.2013.07.038
Figure 9 13C MAS NMR spectrum of VDDAP.
Figure 10 Gel electrophoresis diagram for DNA cleavage
studies of kDNA by VDDAP in a buffer at 37 C: lane,
M= kDNA/EcoRI + Hind III enzyme, lane
ve = kDNA+Hind-III enzyme + without VDDAP, lane + -
ve = kDNA+Hind-III enzyme + FeSO4, lane VDDAP = kD-
NA+Hind-III enzyme + VDDAP.
Table 1 MIC in lg mL1 for antimicrobial activity of VDDAP.
Compound Gram-positive bacteria Gram-negativ
Staphylococcus aureus Bacillus subtilis Proteus vulga
VDDAP 16 18 22
Ampicillin 12 14 16
Clotrimazole – – –
Note: () sign indicates no inhibition.
6 A. Rajini et al.
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rized in Table 1, are compared with those of the standard drug
ampicillin for bacteria and clotrimazole for fungi. VDDAP
displayed good anti-bacterial values against the Gram-positive
strains. VDDAP inhibits the growth of bacteria and most of
the MIC values were found in between 16 and 26 lg mL1.
VDDAP shows the maximum anti-bacterial activity against
S. aureus (Gram-positive) strain with an MIC value of
16 lg mL1 and least against P. ﬂuorescens (Gram-negative)
bacteria with an MIC value of 26 lg mL1 respectively. The
MIC value against E. coli was found to be 20 lg mL1. The
anti-fungal activity of VDDAP against C. albicans shows an
MIC value of 18 lg mL1. Antimicrobial activity depends on
the properties of amine side chains (Bonilla and Garcı´a,
2012). Increase in the alkyl chain length of amine increases
the hydrophobic interaction compatible with the lipid bilayer
of the cell wall and in turn increases the antimicrobial activity
(Sauvet et al., 2000). The dodecylamine in VDDAP provides a
hydrophobic segment compatible with the bilayer of the outer
cell wall and in turn increases the antimicrobial activity.
3.9. Nematicidal activity
The results of nematicidal activity of VDDAP onM. incognita
are given in Table 2. From the results the highest nematicidal
activity was observed at high concentrations and the activity
was found to increase with increase in incubation time. It
was found that the percentage mortality was increased from
54% to 66% with an increase in concentration from 150 to
250 lg mL1 in a 48 h incubation time.
3.10. DNA cleavage studies
Gel electrophoresis experiment using kDNA was performed
with the VDDAP. Fig. 10 shows the gel electrophoresis result.
The DNA cleavage activity of VDDAP was evaluated by the
conversion of super coiled DNA (SC, form I) to nicked circu-
lar (NC form II) or linear DNA (LC form III). It was found
that the lane VDDAP clearly shows the absence of marker
bands and without using any oxidant, VDDAP shows good
DNA cleavage activity (Fig. 10, lane VDDAP). We also car-
ried control experiments (ve and +ve) under similar experi-
mental conditions. In the Fig. 10 the ve control (kDNA+
without VDDAP) does not show cleavage activity and +ve
control (kDNA+ FeSO4) shows a good DNA cleavage
activity.
3.11. Cytotoxicity
The results of cytotoxicity of VDDAP are shown in Table 3. It
was found that the VDDAP shows a dose dependent antie bacteria Fungus
ris Pseudomonas ﬂuorescens Escherichia coli Candida albicans
26 20 18
16 16 –
– – 10
terization, antimicrobial and cytotoxic studies of a novel vana-
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Table 3 Cytotoxicity studies of VDDAP on HL60, HeLa and MCF7 cancer cell lines using sulforhodamine B assay.
Cell lines LC50 TGI GI50
VDDAP Adriamycin VDDAP Adriamycin VDDAP Adriamycin
HL60 >80 >80 47.8 43.8 11.6 <10
HeLa 60.5 28.8 42.9 <10 25.4 <10
MCF7 >80 55.2 62.7 15.8 29.1 <10
Adriamycin was used as positive control drug.
Figure 11 Cytotoxicity studies of (a) VDDAP on HL60 against Adriamycin (HL60) (b) VDDAP on MCF7 against Adriamycin (MCF7)
(c) VDDAP on HeLa against Adriamycin (HeLa).
Table 2 Nematicidal activity (% mortality) on Meloidogyne incognita at different time intervals. % Mortality observed against
different concentrations.
Compound After 24 h After 48 h
Concentration lg mL1 250 lg mL1 150 lg mL1 50 lg mL1 250 lg mL1 150 lg mL1 50 lg mL1
VDDAP 35 20 10 66 54 33
Synthesis, characterization, antimicrobial and cytotoxic studies of a novel vanadium dodecylamino phosphate 7proliferative effect toward cancer cell lines. According to the
dose response curves, the VDDAP had strong inhibitory effect
on cancer cell lines. Estimations based on GI50 values show
that VDDAP exhibits excellent anticancer activity on HL60
cells (GI50 = 11.6 lg mL1) at 40 and 80 lg mL1 concentra-
tions and good activity on MCF7 (GI50 = 29.1 lg mL1) and
HeLa (GI50 = 25.4 lg mL1) cell lines at 80 lg mL1 concen-
tration levels (Fig. 11). Interestingly, VDDAP shows a signiﬁ-
cant and interesting cytotoxicity on HL60 than HeLa and
MCF7 cell lines respectively and suggests the potential for fu-
ture development of VDDAP as a cell type speciﬁc inhibitor.
4. Conclusions
This paper demonstrates, the synthesis of a novel VDDAP at
ambient temperature by employing a vanadium precursor in
the presence of phosphate using organic amine as the template.
The powder XRD data suggest the presence of VOPO4 and hy-
drated VOPO4 phases in the framework of the material. Fi-
brous nature of the synthesized material has been conﬁrmed
from the SEM micrograph. The presence of –V‚O and –V–
O–P– bonds in the framework was conﬁrmed by the presence
of the corresponding vibration bands of the infrared and Ra-
man spectra. The coexistence of V4+ and V5+ in the frame-
work was suggested from the UV–Vis DRS studies. The 31PPlease cite this article in press as: Rajini, A. et al., Synthesis, charac
dium dodecylamino phosphate. Arabian Journal of Chemistry (20MAS NMR spectrum revealed the phosphorous atoms to be
of the VOPO4 phases.
13C suggests the interaction of an amino
group with the vanadium phosphate matrix. The material
exhibits a good antimicrobial activity against Gram-positive
strains and nematicidal activity at high concentrations.
VDDAP promotes the cleavage of kDNA and also explored
for in vitro cytotoxicity on cancer cell lines observing that
the material is active on all cell lines. However, VDDAP shows
good cytotoxicity on HL60 with high GI50 value than HeLa
and MCF7 cell lines. VDDAP also exhibits a dose dependent
cytotoxic effect on cancer cell lines. In conclusion, the material
VDDAP represents a potentially active novel drug with respect
to its antimicrobial, DNA binding and a promising strategy in
the treatment of leukemia.Acknowledgements
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